In AD patients, insulin receptor substrate 1 (IRS-1) deficiency down-regulates Nrf2/HO-1 signaling, thereby increasing oxidative stress in the brain and ultimately causing nerve cell damage. This evidence concerns the gene IRS1 and Alzheimer disease.